First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
Lee, Siow Ming, Prof, Khan, Iftekhar, MSc, Upadhyay, Sunil, MD, Lewanski, Conrad, FRCP, Falk, Stephen, MD, Skailes, Geraldine, FRCR, Marshall, Ernie, MD, Woll, Penella J, Prof, Hatton, Matthew, FRCR, Lal, Rohit, MRCP, Jones, Richard, FRCR, Toy, Elizabeth, FRCR, Chao, David, DPhil, Middleton, Gary, MD, Bulley, Sue, SRN, Ngai, Yenting, BSc, Rudd, Robin, MD, Hackshaw, Allan, Prof, Boshoff, Chris, Prof
Published in The lancet oncology (01.11.2012)
Published in The lancet oncology (01.11.2012)
Get full text
Journal Article
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
Landau, David B., MRCP, Hughes, Laura, NDipSc, Baker, Angela, MSc, Bates, Andrew T., MBBS, Bayne, Michael C., MD, Counsell, Nicholas, MSc, Garcia-Alonso, Angel, MD, Harden, Susan V., DM, Hicks, Jonathan D., FRCR, Hughes, Simon R., FRCR, Illsley, Marianne C., MA, Khan, Iftekhar, PhD, Laurence, Virginia, FRCR, Malik, Zafar, FRCR, Mayles, Helen, MSc, Mayles, William Philip M., PhD, Miles, Elizabeth, MPhil, Mohammed, Nazia, FRCR, Ngai, Yenting, BSc, Parsons, Emma, BHSc, Spicer, James, FRCP, Wells, Paula, PhD, Wilkinson, Dean, MSc, Fenwick, John D., PhD
Published in International journal of radiation oncology, biology, physics (01.08.2016)
Published in International journal of radiation oncology, biology, physics (01.08.2016)
Get full text
Journal Article